CVE-2024-10476

highpriority · track · 0OT risk · elevatedEPSS 0.002 · 14 %ileEUUS
grimoire priorityP2 · Scheduled
Exploitable?
—
no known exploitation
Likely / severe?
0.24% (14th) EPSS
CVSS 8 · high
Is it mine?
18 products
Check your exposure
Who says so?
3 sources
cnnvd · enisa_euvd · cisa_csaf_ot

EPSS · scored 2026-10-27

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

A vendor fix is available.

  • FixedBD Synapsys Informatics Solutioncisa_csaf_ot

    Note: BD Synapsys Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys Informatics Solution installed on a user-provided virtual machine or on the BD Kiestra SCU hardware is not in scope.

  • MitigationBD BACTEC Blood Culture Systemcisa_csaf_ot

    BD has already communicated to users with affected products and is working with them to update default credentials on affected products. For this vulnerability to be exploited, a threat actor will need direct access, whether logical or physical, into the clinical setting.

  • MitigationBD COR Systemcisa_csaf_ot

    BD has already communicated to users with affected products and is working with them to update default credentials on affected products. For this vulnerability to be exploited, a threat actor will need direct access, whether logical or physical, into the clinical setting.

  • MitigationBD EpiCenter Microbiology Data Management Systemcisa_csaf_ot

    BD has already communicated to users with affected products and is working with them to update default credentials on affected products. For this vulnerability to be exploited, a threat actor will need direct access, whether logical or physical, into the clinical setting.

  • MitigationBD MAX Systemcisa_csaf_ot

    BD has already communicated to users with affected products and is working with them to update default credentials on affected products. For this vulnerability to be exploited, a threat actor will need direct access, whether logical or physical, into the clinical setting.

  • MitigationBD Phoenix M50 Automated Microbiology Systemcisa_csaf_ot

    BD has already communicated to users with affected products and is working with them to update default credentials on affected products. For this vulnerability to be exploited, a threat actor will need direct access, whether logical or physical, into the clinical setting.

  • MitigationBD Synapsys Informatics Solutioncisa_csaf_ot

    BD has already communicated to users with affected products and is working with them to update default credentials on affected products. For this vulnerability to be exploited, a threat actor will need direct access, whether logical or physical, into the clinical setting.

02

cvss

Technical severity, 0–10. One row per scoring source.

8.0
010

base score 0–10 · higher = more severe · hover a vector to decode

v3.18highCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Hsecondary · CISA US
v3.18highCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Hsecondary · ENISA EU
v3.18highCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:Hsecondary · cybersecurity@bd.comexploitability 2.1 · impact 5.9
v3.17.3highCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H/E:Usecondary · CVSS-BT (t0sche)
03

ssvc

A stakeholder decision — act, attend, or track — from exploitation and impact.

Exploitation: none · Automatable: no · Technical Impact: totalcoordinatorcisa_ssvcUS
04

weaknesses

The CWE weakness classes this flaw belongs to.

CWE-1392USCWE-1392US
05

affected products (18)

Products and version ranges known to be affected.

06

advisories (1)

Vendor and ecosystem advisories describing this.

  • ICSMA-24-352-01BD Diagnostic Solutions Products (Update A)2024-12-17icsa · cisa_csaf_otUS

    Successful exploitation of this vulnerability could allow an attacker to use default credentials to access, modify, or delete sensitive data, which could impact the availability of the system or cause a system shutdown.

07

also known as (3)

Other names and identifiers for this entity.

08

sources

Which sources assert this record, and when.

cnnvdenisa_euvdcisa_csaf_otNVDCVE.orgMITRE
published 2024-12-17modified 2026-06-17
09

references (3)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan